Envoy Medical COCH Induced Conversion Of Series A Preferred Stock Into Class A Common Stock
Induced Conversion Of Series A Preferred Stock Into Class A Common Stock at other companies
Other financials
Where this comes from
Reported directly by Envoy Medical in its filing.
Tagged under the XBRL concept coch:InducedConversionOfSeriesAPreferredStockIntoClassACommonStock.
The official record: Envoy Medical’s 10-K, filed March 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about Envoy Medical's induced conversion of series a preferred stock into class a common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Envoy Medical's induced conversion of series a preferred stock into class a common stock?
- Envoy Medical (COCH) reported induced conversion of series a preferred stock into class a common stock of $290.5K in Q4 2024.
- What does induced conversion of series a preferred stock into class a common stock mean?
- Reflects the accounting impact of incentivizing preferred shareholders to convert their holdings into common equity, often involving additional consideration or favorable terms. This metric is used to track changes in capital structure and the dilution effects resulting from equity-linked financing arrangements. It provides transparency into the cost of managing the company's preferred equity stack.